Which weight loss injection tends to cause fewer side effects?

What the trial data actually recorded about side effects

The SURMOUNT-1 study of tirzepatide (Mounjaro) and the STEP 1 study of semaglutide (Wegovy) both reported gastrointestinal events as the leading side effects in their respective trial populations. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that nausea affected roughly 30–40% of participants depending on dose, with vomiting and diarrhoea less common but still reported. Rates were consistently lower in participants who followed the gradual titration protocol faithfully. The STEP 1 trial reported a broadly similar pattern for semaglutide, with nausea the most frequently reported complaint.

Comparing the two medicines head-to-head on tolerability is difficult because SURMOUNT-1 and STEP 1 were not designed to answer that question directly. The SURMOUNT-5 open-label trial placed them side by side and found that both medicines produced gastrointestinal side effects at comparable rates, with no clear overall winner on tolerability. What both trials consistently showed is that effects were most pronounced around dose increases and eased as participants settled at a given level.

The practical read-through: neither injection is side-effect-free, but both are designed to be as manageable as possible through gradual dose escalation. Individual response varies considerably, which is why a prescriber's assessment matters, a person's medical history, existing digestive conditions and current medicines all shift the tolerability picture.

The side effects that need same-day or emergency care

Most of what people experience on these medicines is uncomfortable rather than dangerous. Nausea that fades by afternoon, feeling fuller than usual, or loose stools in the first week of a new dose are the kinds of reports our clinical team hears regularly. They pass. But some symptoms fall into a different category.

In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines confirming that acute pancreatitis (while infrequent) is a recognised serious risk. The symptom to know is severe, persistent stomach pain that spreads towards the back, with or without vomiting. Stop treatment and get assessed urgently if that happens. The MHRA's Drug Safety Update page holds the full communication.

Other signs that warrant prompt medical attention include symptoms of significant dehydration from prolonged vomiting or diarrhoea, a suspected allergic reaction (rash, swelling, breathing difficulty), or gallbladder pain (upper-right abdominal discomfort, sometimes with fever or jaundice). The NHS tirzepatide medicines page and the equivalent semaglutide page set out these warning signs clearly. Read them before you start treatment. And if you're ever unsure whether a symptom needs urgent care, call 111 or your GP rather than waiting.

Practical factors that influence how well you tolerate either injection

Beyond the medicine itself, several habits have a measurable impact on side-effect burden. Eating smaller, lower-fat meals reduces the risk of nausea and vomiting, particularly during the early weeks. Keeping well hydrated matters more than it sounds, even mild dehydration amplifies GI discomfort. Injecting on the same day each week, at a consistent time, helps your body settle into a rhythm. Rotating injection sites (abdomen, thigh or upper arm) minimises local soreness.

Our guide to side effects of weight loss injections covers these practical strategies in detail. If you're specifically trying to compare tolerability profiles between medicines before making a decision, the page on which weight loss injection has fewer side effects walks through the evidence in more depth. And for anyone considering fat-dissolving injections instead, it's worth knowing those are a completely different category of procedure, not GLP-1 medicines, with a distinct profile of risks.

Tolerability is also a moving target. People who struggle in the first four weeks often find things markedly better by week eight. Prescribers at a service like ours review your progress before any dose increase, which is the safest approach to managing this, not moving up a level until your body is ready is the most evidence-aligned way to reduce side effects over the course of treatment.

When to talk to a prescriber before, not after, a problem arises

A consultation is the right place to flag anything that might affect how you tolerate these medicines. A history of inflammatory bowel disease, gastroparesis, previous pancreatitis, or frequent gallstones all shift the prescriber's calculation. So does a long list of oral medicines taken at the same time, since both injections slow gastric emptying and can affect how quickly other drugs are absorbed.

The process of getting a weight loss injection through a regulated UK pharmacy starts with that disclosure conversation. At nume, a real clinician reads every consultation form, not a decision algorithm, and if you want to understand which options tend to be better tolerated from the outset, our page on the best weight loss injection without side effects sets out what the evidence currently suggests. The aftercare team is available seven days a week if a side effect crops up between reviews. If you'd like to understand more about what treatment could involve for your specific circumstances, the free consultation is where that conversation starts.